Walleye Trading’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Walleye Trading’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-182,197	Closed	-$1.97M	–	5722
2023 Q3	$1.97M	Hold	182,197	–	–	0.01%	1786
2023 Q2	$1.94M	Buy	182,197 +146,197	+406%	+$1.54M	0.01%	1670
2023 Q1	$376K	Hold	36,000	–	–	﹤0.01%	3033
2022 Q4	$368K	Hold	36,000	–	–	﹤0.01%	3076
2022 Q3	$362K	Hold	36,000	–	–	﹤0.01%	3216
2022 Q2	$358K	Hold	36,000	–	–	﹤0.01%	3233
2022 Q1	$356K	Buy	+36,000	New	+$355K	﹤0.01%	3282

Walleye Trading's BIOS Position: Q4 2023 in Review

Walleye Trading sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 182,197 shares — an estimated $1.97M sold.

Walleye Trading first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $1.97M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Walleye Trading reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 182,197 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $1.97M.
Walleye Trading first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Walleye Trading's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $1.97M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.